Financial Analysis and Stock Valuation: Tanger Factory Outlet Centers, Inc. (SKT), Abbott Laboratories (ABT)

Tanger Factory Outlet Centers, Inc. (NYSE:SKT) shares were trading higher by 0.91 percent ($0.22) at $24.49 a piece in Monday’s session. It had closed the previous session at $24.27. SKT trades with a P/S ratio of 4.79. This is lower than the both industry’s 10.55 and the wider sector’s 6.16. A low price-to-sales ratio, typically less than 1.0, is considered a good value. Also, it has an estimated price-earnings (P/E) multiple of 22.51 and a trailing 12-month price-earnings (P/E) multiple of 39.37. Shares of SKT have downtrended -0.37% in the past three months, while the S&P 500 has moved -8.15% in that time. Tanger Factory Outlet Centers, Inc. (SKT) has a market cap of $2.33 billion and over the last 12 months, Tanger Factory Outlet Centers, Inc. (NYSE:SKT) has gone weaker by -29.04%. During the last 52 weeks, the (NYSE:SKT) price has been as high as $37.34 and as low as $21.81. Tanger Factory Outlet Centers, Inc. earnings have risen with an annualized rate of 30.9% over the last 5 years.

Tanger Factory Outlet Centers, Inc. (Mean Target Price: $26.88)

The average 1-year price target for Tanger Factory Outlet Centers, Inc. (SKT) — averaging the work of different analysts — reveals a mean PT of $26.88/share. That’s a potential 9.76 increase relative to where Tanger Factory Outlet Centers, Inc. (NYSE:SKT) has been trading recently. The current price is seen ranging between $23.74 and $24.67. There are brokerage firms with lower targets than the average, including one setting a price target of $23.9. And then on the other side of the spectrum one analyst entrenched in the bullish camp has a target as high as $31.

Tanger Factory Outlet Centers, Inc. (SKT) Consensus Recommendation

The collective rating of 2.8 for Tanger Factory Outlet Centers, Inc. (NYSE:SKT) also leans strongly towards the neutral end of the spectrum. Of the 10 analysts surveyed by Reuters that track SKT 9 of them rate its stock a hold. The other 1, though not evenly; between analysts who think you should buy Tanger Factory Outlet Centers, Inc. versus those who think you should sell it. A 1 analysts rate it as either a buy or a strong buy, while0 believe that investors should either steer clear of SKT or, if they already own its stock, sell it.

Is Abbott Laboratories (NYSE:ABT) Cheap From Peers?

Abbott Laboratories (ABT) pulled off a 0.91 percent gain and now trades for $55.3. ABT comes in with a P/S ratio of 3.88 that’s greater than 1, potentially implying that it could be expensive relative to the overall sector (5.08) and its peers (3.78). Also, it has an estimated price-earnings (P/E) multiple of 19.57 and a trailing 12-month price-earnings (P/E) multiple of 45.59. During the last 52 weeks, the price has been as high as $56.69 and as low as $37.38. Abbott Laboratories (NYSE:ABT) earnings have declined with a quarterly rate of -0.5% over the last 5 years. Shares of ABT have increased 13.27% in the past three monthswhile the S&P 500 has gained 6.73% in that time.

Abbott Laboratories (Price Objective: $60.29)

Abbott Laboratories (NYSE:ABT) has a market cap of $97.4 billion and over the last 12 months, ABT has risen by 37.77%. The average 1-year price target for (ABT) reveals an average price target of $60.29 per share. That’s a potential 9.02 gain from where (NYSE:ABT) has been trading recently. There are brokerage firms with lower targets than the average, including one setting a price target of $47. And then on the other side of the spectrum one analyst entrenched in the bullish camp has a target as high as $68.

Analyst Thoughts About Abbott Laboratories (NYSE:ABT)

The consensus recommendation — averaging the work of 19 analysts — of 2 for Abbott Laboratories (ABT) points to moderate case. Of the analysts surveyed by Reuters that track Abbott Laboratories 6 of them rate its stock a hold. The other 13 are split, though not evenly, between analysts who think you should buy its stock versus those who think you should sell it. A 13 analysts rate it as either a buy or a strong buy, while 0 believe that investors should either steer clear of (NYSE:ABT) or, if they already own its stock, sell it.